shriya laturwar
posted a blog.
Vascular Patches Market Research Report by Material (Biologic Vascular Patches, Synthetic Vascular Patches), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms Vascular Bypass Surgery, and Others), End-user (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region- Forecast till 2027
Market Analysis
The global vascular patches market is poised to touch USD 6.1 billion at a notable 4.1% CAGR over the predicted years (2018-2023). Vascular patches are utilized in vascular surgeries for closing sutures. In every surgical procedure, the primary closure of sutures needs to be done effectively. Vascular patches are made from synthetic or biological materials and are characterized through excellent biocompatibility. Of the different types, it is the biological vascular patches that are most widely used owing to its various advantages such as excellent biocompatibility, low suture line bleeding, minimum infection rate and ease in use.
There are plentiful factors that is boosting the growth of the vascular patches market. These factors as per the Market Research Future (MRFR) report include rapidly increasing geriatric population, prevalence of vascular diseases, growing number of vascular surgeries being performed, growing use of biological patches, need for minimally invasive surgeries and increasing product launches and research and development investments. On the contrary, scarcity of skilled professionals, mishandling, decrease in carotid endarterectomy surgeries owing to low preference are factors that may restrict the growth of the vascular patches market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6652 ;
Market Segmentation
MRFR report provides an extensive segmental analysis of the vascular patches market on the basis of application, material and end-user.
Based on material, it is segmented into synthetic vascular patches and biologic vascular patches. Of these, the biologic vascular patches will have the maximum share in the market over the predicted years followed by synthetic vascular patches that will grow at the fastest pace.
Based on application, the vascular patches market is segmented into open repair of abdominal aortic aneurysms vascular bypass surgery and carotid endarterectomy. Of these, carotid endarterectomy will dominate the market followed by open repair of abdominal aortic aneurysms vascular bypass surgery which will grow at the fastest rate.
Based on end-user, it is segmented into ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will rule the market followed by ambulatory surgical centers that will grow at the fastest pace.
Regional Analysis
By region, the vascular patches market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will domineer the market over the predicted years and is expected to expand at a substantial CAGR. The increasing occurrence of cardiovascular issues in Canada and the US, growing population and increasing per capita healthcare spending will boost the market growth in this region. Also, the rapid uptake of latest devices and technologies in the surgical procedure and the presence of key manufacturers is again boosting the market growth. The vascular patches market in Europe will have the second major share due to the resurging economy, growing awareness regarding vascular patches and procedure advancements and increasing per capita healthcare expenses. The vascular patches market in the APAC region will grow at the fastest pace over the predicted years owing to growing healthcare sector in India and China, increasing geriatric populace, growing awareness regarding healthcare and rising incidence of people suffering from various chronic coronary diseases.
Key Players
Leading players profiled in the vascular patches market include Baxter International Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Labcor Laboratórios Ltda (Brazil), Admedus (Australia), CryoLife, Inc. (U.S.), W. L. Gore & Associates, Inc. (US), LeMaitre Vascular, Inc. (U.S.), Maquet (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), C.R. Bard, Inc. (U.S.) and others.
April 2019- Tel Aviv University researchers have come up with the world’s first ever 3D printed heart that is perfectly functioning, anatomically, biochemically, cellular and immunologically matched. The heart will be vascularized and supplied through the patient’s blood vessels and created from the own cells of the patient. This new study is called “3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts” and throws light on the fact that should a 3D printed heart be made from the own cells of the patient and transplanted, there can be higher transplant success.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/vascular-patches-market-6652 ;
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Be the first person to like this.
shriya laturwar
posted a blog.
Lupus Market Research Report by Type (Systemic Lupus Erythematosus, Neonatal Lupus, Others), Treatment (NSAIDS, Corticosteroid, Antimalarial Drug, Biologics, Other), End User (Hospital & Clinics, Diagnostic Laboratories, Others), and Region-Forecast till 2027
Lupus is a chronic autoimmune disease which occurs when the immune system attacks the healthy cells and tissues of the body, thereby causing inflammation, pain, swelling, and damage throughout the body. Many people have an inherit tendency towards developing or attaining lupus, which can be triggered due to certain drugs, infections, or even sunlight. The prevalence of this condition has prompted Market Research Future (MRFR) to take notice and study the global market of the same. As of 2017, the market valuation of Lupus stood at USD 1.48 billion. However, as per the latest studies, the global lupus market is projected to grow significantly during the forecast period with a CAGR of 11.2%.
Various factors such as the growing prevalence of lupus diseases, increasing R&D activities, and continuing medical advancements for the treatment of systemic lupus erythematosus are all identified as key factors driving the growth of the market. Also, the market involves a number of noteworthy companies that are involved in the development of new products and product launches. However, irrespective of the market drivers, constraints such as strict government regulation and rising prices of lupus drugs can severely hamper its market growth during the review period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6636 ;
Market Segmentation
The lupus market segmentation is done on the basis of treatment, end-user, and types.
By treatment, the market includes antimalarial drugs, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, immunosuppressants, and others.
By end-user, the market divides into diagnostic laboratories, hospitals and clinics, and others.
Lastly, by type, the market comprises cutaneous lupus erythematosus, systemic lupus erythematosus, neonatal lupus, and drug-induced lupus erythematosus. The lupus erythematosus market segment is projected to hold the largest market percentage due to the increasing prevalence of such diseases and the increasing drug development over the years.
Regional Analysis
The global lupus market is geographically segmented into the following regions: Americas, Asia Pacific, Europe, and the Middle East & Africa.
The Americas is anticipated to be the most dominant regional market due to a number of factors. This includes the growing prevalence of lupus diseases, rising demand for better treatment options, favorable government initiatives, and the availability of reimbursement. In addition to these, the established healthcare infrastructure facility coupled with the accessibility to biologics are also expected to propel the market growth of this region.
The European market is believed to hold the second-largest market position following the Americas. The growth of the market herein is attributed to the expanding R&D activities and widespread prevalence of lupus diseases.
The Asia-Pacific region is expected to be the fastest-growing regional market. This can be attributed to the growing healthcare sector, the rising incidences of lupus diseases, and increasing regional expansion by prominent market players.
The Middle East & Africa region holds the least market share among all the mentioned regions.
Competitive Landscape
The global lupus market holds a number of noteworthy players, including Merck KGaA, Cadila Healthcare, Mylan N.V., F. Hoffmann-La Roche AG, Aurinia Pharmaceuticals, Inc., GlaxoSmithKline PLC, Eli Lily and Company, Pfizer, Inc., Bristol-Myers Squibb Company, Lycera Corporation, and Sanofi.
Dec 11th, 2018, Neovacs, a pioneer in the field of active immune therapy for treating autoimmune diseases, announced the continuation of its partnership with Centurion Pharma in Lupus (SLE). This is based on the study results of the Phase IIb trial with IFNalpha Kinoid.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/lupus-market-6636 ;
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Be the first person to like this.
shriya laturwar
posted a blog.
Global Bioanalytical Testing Services Market Research Report: By Molecule Type (Small Molecule, Large Molecule), By Test Type (Pharmacokinetics, Pharmacodynamics, Bioanalysis, Bioequivalence, Others) - Forecast to 2027
Market Synopsis:
With the mounting demand for healthcare services, there has been a subsequent rise in demand for drug research. New technologies such as bioanalytical testing have been developed for facilitating drug development, which is likely to revolutionize the healthcare and pharmaceutical industries over the next couple of years. Market Research Future (MRFR) has unfolded in its latest report that the global bioanalytical testing services market is anticipated to mark 12.95% CAGR across the review period 2018 to 2023 to reach a valuation of USD 1867.30 Mn by 2023.
Increasing prevalence of chronic diseases is projected to intensify the demand for research & development across the pharmaceutical industry. It is expected to drive the proliferation of the bioanalytical testing services market in the years to come. However, the high cost of bioanalytical testing is likely to undermine market growth in the forthcoming years.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6573 ;
Market Segmentation:
By molecule type, the global bioanalytical testing services market has been segmented into small molecule and large molecule. The small molecule market is expected to reach USD 1167.23 Mn by 2023 from USD 663.99 Mn in 2018. It is estimated to exhibit a CAGR of 11.94% across the projection period. On the other hand, the large molecule segment is expected to exhibit a relatively higher CAGR of 14.76% over the review period.
By test type, the bioanalytical testing services market has been segmented into pharmacodynamics (PD), bioavailability, pharmacokinetic (PK), bioequivalence, and others. Among these, the pharmacokinetic (PK) segment is expected to reach a valuation of USD 757.61 Mn by 2023 at a CAGR of 13.86% across the forecast period. The pharmacodynamics (PD) segment, on the other hand, is projected to expand at 13.06% CAGR over the review period.
Regional Analysis:
The global bioanalytical testing services market has been segmented into four key regions - Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Americas is expected to lead the expansion of the market over the next couple of years. The regional segment is anticipated to scale a decent valuation of USD 716.73 Mn by 2023 up from USD 399.77 Mn in 2018. In addition, the report highlights that the regional bioanalytical testing services market is expected to register a CAGR of 12.39% over the assessment period. Increasing investments in drug research are being observed in the region, which is projected to catalyze market growth in the forthcoming years.
Europe is prognosticated to reach USD 585.61 Mn mark by 2023 at a CAGR of 12.945 across the review period. It has been assessed to exhibit a similar growth pattern as that of the Americas bioanalytical testing services market. The market in Asia Pacific is projected to develop rapidly over the next couple of years. China and India are the most prominent country-level bioanalytical testing services market of the region. Global leaders are expected to invest in the region owing to low manufacturing and labor cost. This, in turn, is projected to catapult Asia Pacific market on an upward trajectory. The Middle East & Africa is poised to scale a CAGR of 11.76% during the assessment period and reach a valuation of USD 129.92 Mn by 2023.
Competitive Dashboard:
Charles River is one of the key participants of the global bioanalytical testing services market expected to have a share of 23.21% as assessed in the report. Other important players studies in the share analysis are Pharmaceutical Product Development (U.S.), ICON plc (Ireland), WuXi AppTec (U.S.), Covance, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S), inVentiv Health (U.S.), SGS SA (Switzerland), Intertek Group plc (U.K.), Toxikon (U.S.), and Pace Analytical Services, LLC (U.S.). The strategies developed by these players for strengthening market positions include, but are not limited to, mergers and acquisitions, collaborations, rising investments, partnerships, collaborations, etc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/bioanalytical-testing-services-market-6573 ;
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Be the first person to like this.
shriya laturwar
posted a blog.
Magnetic Resonance Imaging (MRI) Systems Market Information: By Type (Open MRI and Close MRI), Field Strength (High-Field MRI Systems), Disease Application (Brain and Neurological MRI), and by End-Users (Hospitals & Clinics) - Forecast Till 2027
Market Overview
The global Magnetic Resonance Imaging (MRI) Systems market 2020 is poised to record USD 5 Billion by 2023 at a 3.5% CAGR over the forecast period.
Market Highlights
This market is motivated primarily by the growing need for non-invasive procedures, the adverse effects of radiation-based imaging, the growth in research and development activities in the life sciences field, and the the use of magnetic resonance imaging ( MRI) systems in drug discovery and preclinical testing processes.
Market expansion, however, is limited by factors such as stringent regulatory approval processes, high instrument prices, a lack of competent operators, and inadequate reimbursement policies for magnetic resonance imaging ( MRI) systems.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6194 ;
Segmental Analysis
Based on type, field power, disease application and end-user, the global market for magnetic resonance imaging ( MRI) systems is segmented.
The market is segmented into open MRI, closed MRI, wide-bore MRI, standard bore MRI, comprise the type segment.
The market is segmented into high-field MRI systems, 1.5 t MRI systems, 3 t MRI systems, low-to-mid-field MRI systems, very high-field MRI systems and others on the basis of field strength.
The industry is segmented into spinal and musculoskeletal MRI, brain and neurological MRI, vaginal and abdominal MRI, breast MRI, cardiovascular MRI, and others with respect to the application of the disorder.
The industry is categorised into medical imaging centres, hospitals and clinics, research labs, and pharmaceutical & biotechnology businesses according to the end consumer.
Regional Overview
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa.
Leading to the growing prevalence of cardiovascular, neurological and ophthalmic diseases linked to the increasing geriatric population, which is a significant cause factor for this disease, America dominates the market for magnetic resonance imaging ( MRI) systems. In addition, factors such as increased government interventions and support for medical device research, increased demand for accurate diagnosis, awareness of the adverse effects of radiation imaging, the potential to provide in-depth photographs of soft tissues and vascular systems, and the involvement of pharmaceutical giants are also driving the growth of the market in this area.
Due to significant driving factors such as the provision of specialised treatment facilities, increased healthcare spending, strong healthcare infrastructure and the thriving medical technology industry due to the participation of major market players, Europe is the second largest market and holds a fair share in the global magnetic resonance imaging ( MRI) systems market. In addition , knowledge about the advantages of Magnetic Resonance Imaging ( MRI) systems over radiation imaging and the willingness of residents to provide diagnostics promotes business development.
It is predicted that Asia Pacific will be the fastest developing region with the most exciting growth prospects. Thus, due to the large customer population, faster adaptation of healthcare technologies, government measures to enhance the quality of healthcare, accessibility of favourable business growth of insurance policies will increase during the forecast period. In addition, due to lower costs of clinical trials and testing, major players have set up their regional offices and production facilities in Singapore , China, Japan , Korea, and Australia, which would make the Magnetic Resonance Imaging ( MRI) systems industry a positive growth curve in the future.
Due to some major reasons , such as lack of knowledge, insufficient connectivity, and access to treatment facilities, the Middle East & Africa is expected to see the least growth in the sector. In the Middle East, due to the growth of the healthcare sector and the growing availability of specialty treatment centres, the United Arab Emirates and Saudi Arabia have the largest market share. Therefore, due to Saudi Arabia, the development of the UAE sector and government measures to improve the standard of health care in the Africa region, the market could show steady growth.
Competitive Dashboard
Market Research Future (MRFR) recognizes the following companies as the major players in the magnetic resonance imaging (MRI) systems market. Some of the players are Siemens AG, Hitachi, Canon Medical Systems, GE Healthcare, Philips, Toshiba Corporation, Toshiba Corporation, Xingaoyi, Aurora Imaging Technologies, Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-systems-market-6194 ;
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Be the first person to like this.